What's Happening?
Resurrect Bio, a UK-based startup, has closed its Series A funding round at $10.3 million to advance its technology that enhances plant disease resistance. The investment, led by Corteva through its Corteva Catalyst platform, will support the development
of disease resistance traits in economically important crops. Resurrect Bio's technology focuses on restoring plants' natural immune systems, which have been compromised by evolving pathogens. The company's FloraFold AI platform identifies protein interactions between crops and pathogens, enabling precise gene edits to bolster plant defenses.
Why It's Important?
This funding round underscores the growing interest in agricultural biotechnology as a means to improve crop resilience and reduce reliance on chemical inputs. By enhancing plants' natural defenses, Resurrect Bio's technology could lead to more sustainable agricultural practices, potentially reducing the environmental impact of farming. The investment also highlights the role of corporate venture capital in supporting innovative agtech solutions. As global food security becomes increasingly important, advancements in crop protection technologies are crucial for ensuring stable food supplies and addressing challenges posed by climate change.
